킵스파마

256940KOSDAQ

48.3 / 100

Reference Date: 2026-09-08

Financial Score16.0 / 40

News Sentiment19.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but ROE is below the industry average. Declined 7.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Kipsis Pharma operates three main business segments: OLED equipment development and supply, battery recycling, and pharmaceutical manufacturing and sales. In the OLED segment, the company is expanding its global market through high-precision equipment and FMM mask development. The recycling segment produces lead ingots from recycled batteries for supply to battery manufacturers. Additionally, the biopharma segment is gaining growth momentum through the development of anticancer drugs and digital therapeutics.

Number of Employees

96people

Average Salary

55.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.41Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

-14.33Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

77.31Industry Average 100.004.0Point

In line with industry avg

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲35.9% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.8% (declining, 3yr)

Detailed News Sentiment

9 totalPositive 7Neutral 2Negative 0Average Sentiment Score 77.2

Neutral
중기부·재경부·산업부·지재처, 뭉쳤다…"공공 미활용 우수기술 안...
정부 부처 간 협력으로 공공 기술 공유 활성화 계획 발표, 킵스파마에 직접적 영향은 제한적.
Neutral
공공분야 미활용 우수기술을 한눈에...범부처 통합 안내
정부 부처 간 협력으로 공공 미활용 기술 정보 공유가 시작되었으나, 킵스파마 주식에 직접적인 영향은 미미하다.
Positive
빅씽크, 올해 매출 100억 넘긴다… "항암제 사업 성장 본격화"
킵스파마의 자회사 빅씽크테라퓨틱스의 매출 성장 발표로 인해 긍정적인 시장 반응이 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 5,710Won52-week high 12,45052-week low 5,320

1-month return1.0Point

1m -7.00% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral파생상품거래손실발생2026-08-18
Neutral반기보고서 (2026.06)2026-08-14